740 related articles for article (PubMed ID: 21788989)
41. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.
Garrido E; Carrera E; Manzano R; Lopez-Sanroman A
World J Gastroenterol; 2013 Jan; 19(1):17-25. PubMed ID: 23326158
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
Clos-Parals A; Rodríguez-Martínez P; Cañete F; Mañosa M; Ruiz-Cerulla A; José Paúles M; Llaó J; Gordillo J; Fumagalli C; Garcia-Planella E; Ojanguren I; Cabré E; Guardiola J; Domènech E
J Crohns Colitis; 2019 Mar; 13(3):385-388. PubMed ID: 30346606
[TBL] [Abstract][Full Text] [Related]
44. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
Barkholt L; Linde A; Falk KI
Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
[TBL] [Abstract][Full Text] [Related]
45. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis.
Kim JW; Boo SJ; Ye BD; Kim CL; Yang SK; Kim J; Kim SA; Park SH; Park SK; Yang DH; Jung KW; Kim KJ; Byeon JS; Myung SJ; Kim JH
J Crohns Colitis; 2014 Jul; 8(7):693-701. PubMed ID: 24405983
[TBL] [Abstract][Full Text] [Related]
46. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
47. Management of cytomegalovirus infection in inflammatory bowel diseases.
Pillet S; Pozzetto B; Jarlot C; Paul S; Roblin X
Dig Liver Dis; 2012 Jul; 44(7):541-8. PubMed ID: 22538204
[TBL] [Abstract][Full Text] [Related]
48. [Cytomegalovirus infection in patients with ulcerative colitis].
Baryshnikov EN; Drozdov VN; Shuliat'ev IS; Parfenov AI; Lazebnik LB
Eksp Klin Gastroenterol; 2010; (10):25-8. PubMed ID: 21434367
[TBL] [Abstract][Full Text] [Related]
49. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
[TBL] [Abstract][Full Text] [Related]
50. Refractory ulcerative colitis complicated by a cytomegaloviral infection requiring surgery: report of a case.
Nakamura T; Nakamura R; Maruyama K; Fukazawa A; Uno A; Hayashi T; Higashi Y; Hosoda Y; Nakamura S
Surg Today; 2004; 34(1):68-71. PubMed ID: 14714233
[TBL] [Abstract][Full Text] [Related]
51. Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.
Boivin G; Handfield J; Toma E; Lalonde R; Bergeron MG
J Infect Dis; 1999 May; 179(5):1101-7. PubMed ID: 10191210
[TBL] [Abstract][Full Text] [Related]
52. Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naïve ulcerative colitis.
Inoue K; Wakabayashi N; Fukumoto K; Yamada S; Bito N; Yoshida N; Katada K; Uchiyama K; Ishikawa T; Handa O; Takagi T; Konishi H; Yagi N; Kokura S; Kishimoto M; Yanagisawa A; Naito Y
Intern Med; 2012; 51(19):2739-43. PubMed ID: 23037465
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis.
Esen S; Saglik I; Dolar E; Cesur S; Ugras N; Agca H; Merdan O; Ener B
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793573
[TBL] [Abstract][Full Text] [Related]
54. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
Grzywacz M; Deayton JR; Bowen EF; Wilson P; Emery VC; Johnson MA; Griffiths PD
J Med Virol; 1999 Nov; 59(3):323-8. PubMed ID: 10502264
[TBL] [Abstract][Full Text] [Related]
55. Looking for endoscopic features of cytomegalovirus colitis: a study of 187 patients with active ulcerative colitis, positive and negative for cytomegalovirus.
Iida T; Ikeya K; Watanabe F; Abe J; Maruyama Y; Ohata A; Teruyuki S; Sugimoto K; Hanai H
Inflamm Bowel Dis; 2013 May; 19(6):1156-63. PubMed ID: 23619714
[TBL] [Abstract][Full Text] [Related]
56. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
57. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
Antretter H; Höfer D; Klaus A; Larcher C; Margreiter J; Margreiter R
Dtsch Med Wochenschr; 2000 Apr; 125(15):445-51. PubMed ID: 10800441
[TBL] [Abstract][Full Text] [Related]
58. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
Inokuchi T; Kato J; Hiraoka S; Suzuki H; Nakarai A; Hirakawa T; Akita M; Takahashi S; Harada K; Okada H; Yamamoto K
World J Gastroenterol; 2014 Jan; 20(2):509-17. PubMed ID: 24574719
[TBL] [Abstract][Full Text] [Related]
59. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic.
Schenk W; Klugmann T; Borkenhagen A; Klecker C; Dietel P; Kirschner R; Schneider E; Bruns T; Stallmach A; Teich N
Int J Colorectal Dis; 2019 Mar; 34(3):393-400. PubMed ID: 30506156
[TBL] [Abstract][Full Text] [Related]
60. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.
Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y
Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
